Literature DB >> 30071294

Effects of 10 MV and Flattening-Filter-Free Beams on Peripheral Dose in a Cohort of Pediatric Patients.

Youssef Ben Bouchta1, Karen Goddard2, M Peter Petric3, Alanah M Bergman4.   

Abstract

PURPOSE: To assess the effect of flattening-filter-free (FFF) and 10 MV radiation therapy beams on the peripheral dose received by a population of pediatric patients undergoing volumetric modulated arc therapy (VMAT). METHODS AND MATERIALS: Twenty-six previously delivered 6 MV flattened VMAT pediatric radiation therapy treatments plans were replanned with 6 MV flattened, 6 MV FFF, and 10 MV FFF VMAT. Monte Carlo simulation code EGSnrc was used in conjunction with a measurement-based model to obtain 3-dimensional dose distributions. Peripheral dose delivered by FFF beams was compared with that delivered by 6 MV flattened beams. A statistical analysis was performed to determine whether certain clinical factors (eg, target volume, location) were associated with a change in integral relative radiation dose. Neutron dose measurements assessed the neutron contribution from the 6 MV flattened and 10 MV FFF x-ray beams.
RESULTS: Both the 6 MV FFF and 10 MV FFF beams delivered significantly lower peripheral radiation doses than 6 MV flattened (P < .01). The dose reduction was of 3.9% (95% confidence interval [CI] 2.1-5.7) and 9.8% (95% CI, 8.0-11.6) at 5 cm from the PTV and 21.9% (95% CI, 13.7-30.1) and 25.6% (95% CI, 17.6-33.6) at 30 cm for 6 MV FFF and 10 MV FFF beams, respectively. The clinical factors examined did not have a significant effect on the relative magnitude of the peripheral dose reduction. The upper limit on the neutron dose was determined to be 203 μSv for the 6 MV flattened and 522 μSv for the 10 MV FFF beam.
CONCLUSIONS: Both FFF beams significantly (P < .01) reduced the peripheral dose. 10 MV FFF was more effective at reducing peripheral dose at distances <5 cm from the PTV edge. The neutron doses delivered by all beams were <1% compared with the photon doses. 10 MV FFF should be used to minimize peripheral dose.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30071294     DOI: 10.1016/j.ijrobp.2018.07.2002

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  2 in total

1.  Feasibility of a GATE Monte Carlo platform in a clinical pretreatment QA system for VMAT treatment plans using TrueBeam with an HD120 multileaf collimator.

Authors:  Boram Lee; Seonghoon Jeong; Kwangzoo Chung; Myonggeun Yoon; Hee Chul Park; Youngyih Han; Sang Hoon Jung
Journal:  J Appl Clin Med Phys       Date:  2019-09-23       Impact factor: 2.102

2.  Development of a quasi-humanoid phantom to perform dosimetric and radiobiological measurements for out-of-field doses from external beam radiation therapy.

Authors:  Marta Kruszyna-Mochalska; Agnieszka Skrobala; Piotr Romanski; Adam Ryczkowski; Wiktoria Suchorska; Katarzyna Kulcenty; Igor Piotrowski; Dorota Borowicz; Natalia Matuszak; Julian Malicki
Journal:  J Appl Clin Med Phys       Date:  2022-02-01       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.